November 05, 2025

Get In Touch

Optimal Intra-Operative Mitomycin C Dose Improves Success Of Microshunt Implantation Among Glaucoma Patients

Microshunt Implantation Study

Factors Influencing the Success of Microshunt Implantation in Glaucoma Patients

A recent multicenter retrospective cohort study involved 250 eyes from 220 glaucoma patients and identified the factors influencing the success of Microshunt implantation. This study was designed to evaluate risk factors for Microshunt failure, and found the crucial elements that could enhance surgical outcomes for glaucoma patients. The findings were published in the American Journal of Ophthalmology.

Success Criteria and Key Findings

The success criteria were defined based on intraocular pressure (IOP) outcomes, ranging from a reduction to as low as 12mmHg. At the 1-year follow-up, success rates varied between 43.3% and 62.5%, depending on the specific criteria. Notably, the concentration of mitomycin-C (MMC) during surgery emerged as a key determinant. Higher intraoperative MMC concentration was associated with a significantly reduced risk of failure for both complete and overall success.

Risk Factors for Microshunt Failure

The study showed other risk factors contributing to Microshunt failure:

  • Pseudoexfoliation glaucoma/pigmentary glaucoma
  • Primary angle-closure glaucoma
  • A history of non-glaucomatous ocular surgeries

For overall success, factors such as lower preoperative IOP, a higher number of preoperative antiglaucoma agents, and the combination of Microshunt with cataract surgery were identified as significant risk factors.

Implications and Future Directions

These findings underscore the need for precision in surgical approaches and highlight the intricate balance required for optimal outcomes. The study not only provides critical insights into factors influencing Microshunt efficacy but also emphasizes the importance of personalized patient selection for these procedures.

Advancements in glaucoma management continue to evolve and this research opens avenues for refining surgical strategies, offering hope for improved outcomes and quality of life for glaucoma patients. The identification of these risk factors is a crucial step towards enhancing the effectiveness of Microshunt procedures, bringing us closer to more tailored and successful glaucoma interventions.

Source

Rabiolo, A., Toscani, R., Sacchi, M., Destefanis, P., Bettin, P., Ciampi, C., Clemente, A., Cutolo, C. A., Mercieca, K., Iester, M., Traverso, C. E., Maita, M. D., Calzi, G. L., Nucci, P., Bandello, F., Triolo, G., & De Cillà, S. (2023). Risk factors for failure in glaucoma patients undergoing microshunt implantation. American Journal of Ophthalmology. https://doi.org/10.1016/j.ajo.2023.11.011

Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our Terms of Use, Privacy Policy, and Advertisement Policy.
For further details, please review our Full Disclaimer.

0 Comments

Post a comment

Please login to post a comment.

No comments yet. Be the first to comment!